DrugDashboards

Cholestyramine

Cholestyramine · CHOLESTYRAMINE 4 g/4.8g · Powder, For Suspension · Oral · Precision Dose, Inc.

NDC 68094-0906-10 · 201.6 g in 1 CAN · ANDA · View full market →

The short version

14 companies supply this market — deep enough that no single failure threatens the supply. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.1454per GMinvoice-surveyed acquisition cost · Nov 19, 2025
  • Part D plans paid (avg)$0.9488per dosage unitgross, before rebates — matched by drug name · 2024
  • Federal contracts pay (FSS)$51.29per package of 201.6GMAvKare, LLC · Jul 25, 2025

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.1$0.2Apr 2025Nov 2025$0.1454
8 price points · per GM · last surveyed Invalid DateSource: CMS NADAC

Medicaid spend (2025)

$1,434
32 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

0● Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for cholestyramine (other) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA209599
TE code
AB
Approval date
Nov 12, 2020
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Cholestyramine (Powder, For Suspension)

LabelerStrengthFirst seenLast seen
AiPing Pharmaceutical, Inc.CHOLESTYRAMINE 4 g/9gSep 3, 2026Sep 3, 2026
Bryant Ranch PrepackCHOLESTYRAMINE 4 g/9gJul 15, 2026Sep 3, 2026
Par Health USA, LLCCHOLESTYRAMINE 4 g/5gJul 15, 2026Sep 3, 2026
Par Health USA, LLCCHOLESTYRAMINE 4 g/9gJul 15, 2026Sep 3, 2026
Ajanta Pharma USA Inc.CHOLESTYRAMINE 4 g/9gJul 15, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedCHOLESTYRAMINE 4 g/9gJul 15, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedCHOLESTYRAMINE 4 g/5.7gJul 15, 2026Sep 2, 2026
Micro Labs LimitedCHOLESTYRAMINE 4 g/9gJul 15, 2026Sep 2, 2026
Precision Dose, Inc.CHOLESTYRAMINE 4 g/4.8gJul 15, 2026Sep 2, 2026
Precision Dose, Inc.CHOLESTYRAMINE 4 g/9gJul 15, 2026Sep 2, 2026
Puracap Laboratories Llc Dba Blu PharmaceuticalsCHOLESTYRAMINE 4 g/9gJul 15, 2026Sep 2, 2026
TAGI Pharma, Inc.CHOLESTYRAMINE 4 g/4.8gJul 15, 2026Sep 2, 2026
TAGI Pharma, Inc.CHOLESTYRAMINE 4 g/8.3gJul 15, 2026Sep 2, 2026
Upsher-Smith Laboratories, LLCCHOLESTYRAMINE 4 g/5.5gJul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedCHOLESTYRAMINE 4 g/5.5gJul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedCHOLESTYRAMINE 4 g/9gJul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals (USA) Inc.CHOLESTYRAMINE 4 g/9gJul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals (USA) Inc.CHOLESTYRAMINE 4 g/5.5gJul 15, 2026Sep 2, 2026
Bryant Ranch PrepackCHOLESTYRAMINE 4 g/5gJul 15, 2026Aug 29, 2026
Epic Pharma, LlcCHOLESTYRAMINE 4 g/9gJul 15, 2026Aug 28, 2026
Endo USA, Inc.CHOLESTYRAMINE 4 g/5gJul 15, 2026Aug 19, 2026
Endo USA, Inc.CHOLESTYRAMINE 4 g/9gJul 15, 2026Aug 19, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Cholestyramine — NDC 68094-0906-10," retrieved September 3, 2026, https://drugdashboards.com/drug/68094090610.

Free to cite with attribution — see how the data is put together.